3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
2
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thrombocythemia, Essential
1
Recurrence
1
Primary Myelofibrosis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Interventions
pembrolizumab
436
Carboplatin
321
Nivolumab
286
Cyclophosphamide
280
Specimen Handling
257
Cisplatin
252
Magnetic Resonance Spectroscopy
248
Paclitaxel
247
Radiotherapy
218
Dexamethasone
181
Gemcitabine
180
Biopsy
177
durvalumab
166
atezolizumab
147
Rituximab
138
Lenalidomide
134
Doxorubicin
134
Docetaxel
128
Bevacizumab
128
Ipilimumab
126
Radiation
119
Capecitabine
117
Pemetrexed
112
Oxaliplatin
111
Etoposide
111
Radiosurgery
108
Fluorouracil
107
venetoclax
106
fludarabine
106
Prednisone
97
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Interventional
×
INCB057643
×
Clear all
NCT04279847
2026-04-01
LIMBER
Incyte Corporation
Phase 1
Active not recruiting
140 enrolled